Molecular Modeling and Docking Study of 2-Nitropropane Dioxygenase of Mycobacterium tuberculosisAbid AM1*, Ibrahim BS1, Yadav PK1, Arya H1 and Rasool A2
- *Corresponding Author:
- Md Abid Alam
Centre for Bioinformatics
E-mail: [email protected]
Received Date: December 08, 2016; Accepted Date: March 21, 2017; Published Date: March 27, 2017
Citation: Abid AM, Ibrahim BS, Yadav PK, Arya H, Rasool A (2017) Molecular Modeling and Docking Study of 2-Nitropropane Dioxygenase of Mycobacterium tuberculosis. Int J Biomed Data Min 6: 127. doi: 10.4172/2090-4924.1000127
Copyright: © 2017 Abid AM, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Mycobacterium tuberculosis is infectious bacteria and causes tuberculosis in humans. M. tuberculosis infects the immune deficient human and shows the symptoms of the infection. Also bacteria stay in latent phase inside the human body and can be active in suitable conditions. One third of the total population of the world is infected by M. tuberculosis; therefore it is very important to have potential drugs against tuberculosis. Mycobacteria have reported multidrug resistance to the available drugs for tuberculosis. Hence, there is a need to find a new target for the drugs. Fatty acid synthase II (FAS II) is the enzyme that catalyzes the synthesis of fatty acid and is not found in humans. It is a multifunctional polypeptide, composed of different domains in which can be targeted individually to inhibit the function of FAS II. 2-Nitropropane Dioxygenase is a part of enoyl reductase domain in FAS II and can be potentially targeted. In this study, the homology modeling of 2NPD from M. tuberculosis has been done and small molecules that have the potential to bind and inhibit the function of the enzyme have been identified. Also the stability of proteinligand complex was determined.